Proto Labs Inc (PRLB) Director Sells $51,375.00 in Stock

Proto Labs Inc (NYSE:PRLB) Director Rainer Gawlick sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the transaction, the director now owns 10,925 shares of the company’s stock, valued at $1,122,543.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Rainer Gawlick also recently made the following trade(s):

  • On Tuesday, November 21st, Rainer Gawlick sold 1,500 shares of Proto Labs stock. The shares were sold at an average price of $90.31, for a total value of $135,465.00.

Proto Labs Inc (PRLB) traded up $0.15 during trading on Friday, reaching $111.30. 55,033 shares of the company’s stock were exchanged, compared to its average volume of 161,367. The firm has a market cap of $2,970.00, a price-to-earnings ratio of 63.24, a price-to-earnings-growth ratio of 2.42 and a beta of 1.07. Proto Labs Inc has a 52-week low of $48.00 and a 52-week high of $113.05.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings data on Thursday, October 26th. The industrial products company reported $0.56 EPS for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.04. Proto Labs had a net margin of 14.53% and a return on equity of 11.63%. The business had revenue of $88.10 million during the quarter, compared to analyst estimates of $85.68 million. During the same quarter in the prior year, the business earned $0.51 earnings per share. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. research analysts predict that Proto Labs Inc will post 1.89 earnings per share for the current year.

A number of large investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. grew its stake in shares of Proto Labs by 25.3% during the second quarter. Russell Investments Group Ltd. now owns 16,501 shares of the industrial products company’s stock valued at $1,110,000 after purchasing an additional 3,337 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of Proto Labs by 0.9% during the second quarter. Schwab Charles Investment Management Inc. now owns 105,104 shares of the industrial products company’s stock valued at $7,069,000 after purchasing an additional 973 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Proto Labs by 44.2% during the second quarter. Bank of New York Mellon Corp now owns 498,198 shares of the industrial products company’s stock valued at $33,504,000 after purchasing an additional 152,637 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Proto Labs by 11.2% during the second quarter. Legal & General Group Plc now owns 47,003 shares of the industrial products company’s stock valued at $3,161,000 after purchasing an additional 4,744 shares during the last quarter. Finally, BNP Paribas Arbitrage SA grew its stake in shares of Proto Labs by 53.3% during the second quarter. BNP Paribas Arbitrage SA now owns 7,746 shares of the industrial products company’s stock valued at $521,000 after purchasing an additional 2,693 shares during the last quarter.

Several research analysts have issued reports on the company. Zacks Investment Research raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $120.00 target price on the stock in a research note on Saturday, January 13th. Piper Jaffray Companies restated a “hold” rating and set a $84.00 price target on shares of Proto Labs in a report on Thursday, December 14th. BidaskClub cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Friday, October 6th. Finally, Craig Hallum set a $92.00 price objective on shares of Proto Labs and gave the stock a “hold” rating in a report on Monday, November 27th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Proto Labs currently has an average rating of “Hold” and a consensus price target of $86.50.

WARNING: This article was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/28/rainer-gawlick-sells-500-shares-of-proto-labs-inc-prlb-stock.html.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply